News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NanoViricides, Inc. (NNVC.PK) Files Annual Report - Reports Having Sufficient Funds for Current Goals and for Advancing Its Robust Drug Pipeline


10/16/2012 10:03:30 AM

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTCBB: NNVC) (the "Company"), reports that it has filed its financial year end annual report (Form 10-K) with the Securities and Exchange Commission (SEC) in a timely manner on Monday, October 15. The report can be accessed at the SEC website (http://www.sec.gov/Archives/edgar/data/1379006/000114420412056152/v325626_10k.htm). The Company estimates that the cash in hand at year end is sufficient for an additional up to eighteen months or more of operational expenses at the current rate. The Company also believes that it now has sufficient financing to advance its drug pipeline further into the Food and Drug Administration (FDA) approval process.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES